FDC Ltd

NSE: FDC · BSE: 531599 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹329.60
Market cap: ₹5,366 Cr
Revenue (annual): ₹2,171 Cr
Net profit (annual): ₹281.4 Cr
P/E (TTM): 18.3×Sector 47.4×
Promoter holding: 69.66%+0.00% QoQ
FII holding: 1.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 3 Regulatory Approval 1 Promoter Selling (Off-Market) 1 Legal & Regulatory 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Aug 2026 14:23 IST BSE

Regulatory Approval

FDC Regulatory Approval

FDC Limited's subsidiary, FDC International Limited, received marketing authorization from MHRA, UK for Atropine 1.0% eye drops. This regulatory approval enables product commercialization in the United Kingdom.

Read the filing ↗